Litcius/Paper detail

Altered host protease determinants for SARS-CoV-2 Omicron

Jasper Fuk‐Woo Chan, Xiner Huang, Bingjie Hu, Yue Chai, Hongyu Shi, Tianrenzheng Zhu, Terrence Tsz‐Tai Yuen, Yuanchen Liu, Huan Liu, Jialu Shi, Lei Wen, Huiping Shuai, Yuxin Hou, Chaemin Yoon, Jian‐Piao Cai, Jinxia Zhang, Jie Zhou, Feifei Yin, Shuofeng Yuan, Bao‐Zhong Zhang, Melinda A. Brindley, Zheng‐Li Shi, Kwok-Yung Yuen, Hin Chu

2023Science Advances49 citationsDOIOpen Access PDF

Abstract

Successful severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection requires proteolytic cleavage of the viral spike protein. While the role of the host transmembrane protease serine 2 in SARS-CoV-2 infection is widely recognized, the involvement of other proteases capable of facilitating SARS-CoV-2 entry remains incompletely explored. Here, we show that multiple members from the membrane-type matrix metalloproteinase (MT-MMP) and a disintegrin and metalloproteinase families can mediate SARS-CoV-2 entry. Inhibition of MT-MMPs significantly reduces SARS-CoV-2 replication in vitro and in vivo. Mechanistically, we show that MT-MMPs can cleave SARS-CoV-2 spike and angiotensin-converting enzyme 2 and facilitate spike-mediated fusion. We further demonstrate that Omicron BA.1 has an increased efficiency on MT-MMP usage, while an altered efficiency on transmembrane serine protease usage for virus entry compared with that of ancestral SARS-CoV-2. These results reveal additional protease determinants for SARS-CoV-2 infection and enhance our understanding on the biology of coronavirus entry.

Topics & Concepts

ProteasesTransmembrane proteinProteaseMetalloproteinaseCoronavirusSerine proteaseMatrix metalloproteinaseBiologyViral entryVirologyBetacoronavirusCell biologyEnzymeViral replicationVirusCoronavirus disease 2019 (COVID-19)BiochemistryMedicineReceptorPathologyDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesMosquito-borne diseases and control